In fact, Notch1 activation led to repression of neuroendocrine markers apoptosis induction and reduced tumor growth making it an interesting molecule for MTC therapy [43, 44, 58–60]. This evidence concerns the gene NOTCH1 and medullary thyroid gland carcinoma.